About the Journal
Peer Review
A manuscript will be evaluated and reviewed for possible publication with the understanding that it is being submitted to International Journal of Medicine and Biomedical Research alone at that point in time and has not been published anywhere, simultaneously submitted, or already accepted for publication elsewhere. It is expected that authors would authorize one of them to correspond with the Journal for all matters related to the manuscript. All manuscripts received are duly acknowledged. On submission, editors evaluate all submitted manuscripts initially for suitability for formal review. Manuscripts that are short of the Journal’s standard or out of scope are rejected. Manuscripts and figures are not returned to the authors, not even upon rejection of the paper. Suitable manuscripts are peer-reviewed by two or more reviewers who are vast in the field and are not affiliated with the same institutes as the contributor(s). However, selection of reviewers is at the sole discretion of the editor. The Journal follows a single-blind review process. The comments and suggestions received from reviewers are conveyed to the corresponding author. The author is requested to provide a point by point response to reviewers’ comments and submit a revised version of the manuscript. This process is repeated till reviewers and editors are satisfied with the manuscript. The papers submitted must meet the following criteria: • the topic should be of medical and biomedical interest • findings should have clinical significance • the abstract should be adequately informative • the material should be original • the methodology used should be standard, appropriate, and scientific • the statistical methods used should be correct and adequate • results should be unambiguous and supported with data/photographs • conclusions should be reasonable and based on the findings • references must be adequate IJMBR review process is constructive and unbiased. Reasons for rejection include: • out of journal’s scope • too preliminary • lack of novelty • evidence of plagiarism Manuscripts accepted for publication are copy edited and page proofs are sent to the corresponding author. The corresponding author is expected to return the corrected proofs within five days.Open Access Policy
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.General
Focus and Scope
IJMBR publishes editorial, original and review papers, case reports, reports and commentaries, letters to editor and conference proceedings in areas of Clinical and Basic Medical Sciences. It also publishes valuable studies in Allied Medicine, Pharmaceutical Chemistry, and Alternative and Complementary Medicine. Articles must adhere to the recommendations from the Declaration of Helsinki, NIH guidelines for care and use of laboratory animals or International Committee of Medical Journal Editors (ICMJE).
Peer Review Process
A manuscript will be evaluated and reviewed for possible publication with the understanding that it is being submitted to International Journal of Medicine and Biomedical Research alone at that point in time and has not been published anywhere, simultaneously submitted, or already accepted for publication elsewhere. It is expected that authors would authorize one of them to correspond with the Journal for all matters related to the manuscript. All manuscripts received are duly acknowledged. On submission, editors evaluate all submitted manuscripts initially for suitability for formal review. Manuscripts that are short of the Journal’s standard or out of scope are rejected. Manuscripts and figures are not returned to the authors, not even upon rejection of the paper.
Suitable manuscripts are peer-reviewed by two or more reviewers who are vast in the field and are not affiliated with the same institutes as the contributor(s). However, selection of reviewers is at the sole discretion of the editor. The Journal follows a single-blind review process. The comments and suggestions received from reviewers are conveyed to the corresponding author. The author is requested to provide a point by point response to reviewers’ comments and submit a revised version of the manuscript. This process is repeated till reviewers and editors are satisfied with the manuscript.
The papers submitted must meet the following criteria:
• the topic should be of medical and biomedical interest
• findings should have clinical significance
• the abstract should be adequately informative
• the material should be original
• the methodology used should be standard, appropriate, and scientific
• the statistical methods used should be correct and adequate
• results should be unambiguous and supported with data/photographs
• conclusions should be reasonable and based on the findings
• references must be adequate
IJMBR review process is constructive and unbiased. Reasons for rejection include:
• out of journal’s scope
• too preliminary
• lack of novelty
• evidence of plagiarism
Manuscripts accepted for publication are copy edited and page proofs are sent to the corresponding author. The corresponding author is expected to return the corrected proofs within five days.
Open Access Policy
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Editorial Office
Editor-in-chief:
Prof. Sofola O.A. (MB.BS,Ph.D, FAS)
Department of Physiology, College of Medicine, University of Lagos,
Nigeria
CORRESPONDING EDITORS:
- Prof. Aboul-Ata A.E
Plant Pathology Research Institute,Agricultural Research Center, Giza, Egypt.
- Dr. Alejandro Diaz - Moscoso, Marie Curie IntraEuropean Fellow, School of Chemistry, University of East Anglia, NR4 7TJ, Norwich, United Kingdom.
- Dr. Al-Mobeireek A.F.
Department of Maxillofacial Surgery and Diagnostic Sciences, College Of Dentistry, King Saud University, Kingdom of Saudi Arabia.
- Dr. Azeez O.M.
Department of Veterinary Physiology and Pharmacology, Faculty of Veterinary Medicine, University of Ilorin, Ilorin, Nigeria.
- Prof. Basawaraj S.P.
Department of Pharmaceutics, R.M.E.S College of Pharmacy, Balaji Nager, Gulbaraga, Karnatka, India.
- Dr. Budisteanu M.
Paediatric Neurology Unit, Laboratory of Medical Genetics, "Victor Babes" National Institute of Pathology, Also at "Prof. Dr. Alexandru Obregia" Psychiatry Clinical Hospital, Bucharest, Romania.
- Dr. Chakraborty A,
Department of Pharmacology, Vydehi Institute of Medical Sciences, Bangalore-66.
- Dr. Chelluboina B.
University of Illinois College of Medicine, Peoria, USA.
- Dr. Chen L.M
Dana-Farber Cancer Institute, Dr. Kimberly Stegmaier's Lab, Department of Pediatric Hematology and Oncology, 450 Brookline Avenue Boston, MA 02215.
- Dr Cojocaru C.
Pulmonary Unit, Department of Medicine, University of Medicine and Pharmacy, Gr. T. Popa Iasi, 16 University Street, RO-700115, Iasi, Romania
Also at Centre of Medical Oncology, 2 V. Conta Street, Iasi, Romania.
- Prof. Erhabor G.E.
Department of Medicine, Obafemi Awolowo University Teaching Hospital Complex, Ile-Ife, Nigeria.
- Dr. Goulielmos G.N.
Human Molecular Genetics Unit, Department of Internal Medicine, School of Medicine, University of Crete, Heraklion, Greece.
- Dr. Kingsley K.,
Department of Biomedical Sciences, School of Dental Medicine, University of Nevada, Las Vegas, USA.
- Dr. Kumari B.
Department Of Environment and Water Management, A.N. College, Patna 800013, Bihar, India.
- Dr.Lal H.
Center for Translational Medicine, Temple University, School of Medicine, Philadephia USA.
- Dr. Lampiao F.
Department of Physiology, College of Medicine, University of Malawi, P/bag 360, Blantyre 3, Malawi.
- Dr. Lee S.H.
Enzyme Biotechnology Laboratory, Department of Food Science and Biotechnology, Kyungpook National University, Daegu 702-701, Korea.
- Dr. Lehr E.J
Cardiac Surgeon, Director of Cardiac Surgery Research and Education, Co-Director of Minimally Invasive and Robotic Cardiac Surgery, Swedish Medical Group, Seattle, WA, USA.
- Dr Magdy M.D Mohammed
Department of Pharmacognosy, Pharmaceutical and Drug Industries Research Division, National Research Center, Dokki-12311, Cairo, Egypt.
- Dr. Mei X
Department of Physiology and Biophysics, School of Medicine, Boston University, Albany St, W302, Boston, MA 02215, USA
- Dr. Mohammed A.M
Department of Otorhinolaryngology (ENT), Karachi Medical and Dental College, Also at Abbasi Shaheed Hospital, Karachi, Pakistan.
- Dr. Muruganandam M.
Department of Basic Studies, DMI-St.Eugene University, Lusaka, Zambia.
- Prof. Obaleye J.A.
Department of Chemistry, University of Ilorin, Nigeria.
- Prof. Oguntibeju O.O.
Nutrition and Chronic Disease Research Unit, Department of Biomedical Sciences, Faculty of Health and Wellness Sciences, Cape Peninsula University of Technology, South Africa.
- Prof. Okonofua F.E.
Sexuality and Reproductive Health, Ford Foundation, Office For West African Ten, 105 close, Banana Island, Ikoyi, Lagos, Nigeria.
- Dr. Okumu? S.
Department of Ophthalmology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey.
- Dr. Qian J
3801 Miranda Ave, VA Palo Alto Health Care System, Stanford University School of Medicine, Bldg 101, Rm B4-105. Palo Alto, CA 94304
- Dr. Raja Kumar P.
Department of Biochemistry, College of Medicine and Health Sciences, Wollo University, Dessei, Ethiopia.
- Prof. Raja T.K
Department of Chemistry, School of Applied Sciences, College of Engineering, Science and Technology, Fiji National University,
Samabula Campus, Suva, Fiji.
Currently at: Centre for International studies Ton Duc Thang University Ho Chi Minh City, Vietnam.
- Dr. Ran D
Moores Cancer Center, University of California, San Diego, USA, 3855 Health Sciences Drive, La Jolla, CA 92093.
- Prof. Rossi MIstituto
di Biochimica delle Proteine - CNRVia Pietro Castellino n. 111, 80131 Naples, Italy.
- Prof. Sabatier J.M.
Directeur de Recherche Laboratoire ERT-62, Ingénierie des Peptides à Visée Thérapeutique, Université de la Méditerranée-Ambrilia Biopharma Inc., Faculté de Médecine Nord, Bd Pierre Dramard, 13916, Marseille cédex 20, France.
- Dr. Saharan V.A
Department of Pharmaceutical Science, S. Bhagwan Singh PG Institute of Biomedical Sciences and Research, Balawala, Dehradun 248161, Uttarakhand, India.
- Dr. Sezer A.D.
Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Marmara University, Haydarpa?a 34668, Istanbul, Turkey.
- Prof. Sharma R.K.
Academy of Scientific and Innovative Research, Central Drug Research Institute, Lucknow-226001, India.
- Dr. Verma S.K
303 E. Superior ST, Lurie # 10-103, Feinberg Cardiovascular Research Institute (FCVRI), Feinberg School of Medicine, Northwestern University, Chicago, Illinois-60611.
- Dr. Wang S
Department of Genetics, Harvard Medical School and Howard Hughes Medical Institute, NRB Rm 360, 77 Avenue Louis Pasteur, Boston MA, 02115.
- Prof. Wiwanitkit V.
Department of Laboratory Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
- Dr. Zhang Fuxing
620 Grandview Meadows Dr., Unit.F305,Longmont, CO, USA.
- Dr. Zhong L
Department of Endocrinology/Diabetes, School of Medicine, UCSD, La Jolla, CA, USA.
LANGUAGE AND TECHNICAL EDITORS
- Dr. Cao D
Bonner Hall Room 2201, Neurobiology Section, Division of Biological Sciences, University of California, San Diego, 9500 Gilman Dr, La Jolla, CA, 92093, USA
- Dr. Gerard G. Dumancas
Arthritis and Clinical Immunology Research Program, MS58, Oklahoma Medical Research, Foundation, 825 N.E. 13th Street, Oklahoma City, OK USA 73104.
- Dr. Kuddus M
Department of Biochemistry, College of Medicine, University of Hail, Hail, Kingdom of Saudi Arabia.
- Dr. Lu P
Department of Paediatric Oncology, Dana-Farber Cancer Institute, Mayer Building, Room 654, 450 Brookline Avenue, Boston, MA 02215.
- Dr. Ma B
Institute for Genome Sciences, University of Maryland School of Medicine, 801 W. Baltimore St. 410.706.2305, Baltimore, MD 21228, USA.
- Dr. Shi Z
Department of Animal Medicine, South-West University Rongchang, Chongqing, 412460 China.
- Dr. Ye F
Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, FL 32610, USA.
ADMINISTRATIVE MANAGER
Aisabokhae V.J (MBA)
Viani Ruiz Company, Nigeria.
INFORMATION AND COMMUNICATION MANAGER
Omotehinwa T.O. (M.Sc)
Divasoft Technology, Nigeria.
Also at: Department of Mathematical Sciences, Kogi State University Anyigba, Nigeria.
Hard Copy Subscriptions
The Journal charges US $ 200 (for overseas authors) and N 20,000 (for authors from Nigeria) on accepted manuscript.
Subscription type:
Individual: Nigeria (Naira) 10,000
Other (US$) 200
Institution: Nigeria (Naira) 15,000
Other (US$) 250
Sources of Support
- Author-side fees and subscription
